Home/Filings/4/0001209191-22-050612
4//SEC Filing

Tada Hiroomi 4

Accession 0001209191-22-050612

CIK 0001863127other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 6:20 PM ET

Size

4.6 KB

Accession

0001209191-22-050612

Insider Transaction Report

Form 4
Period: 2022-09-15
Tada Hiroomi
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-09-15$7.66/sh+612$4,68781,237 total
Footnotes (1)
  • [F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1
  • filerCIK 0001880593

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 6:20 PM ET
Size
4.6 KB